Skip to main content
OpenTrials
Completed

NCT Number: NCT02246361

Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication

The purpose of this "before-after" prospective multicenter study is to assess the impact of six Patient Information Leaflets (PILs) on Doctor Patient Communication scale (DPC) and adherence scale for common acute illnesses in emergency ward.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Assessing the impact of six Patient Information Leaflets (PILs) on Doctor Patient Communication scale (DPC) and adherence scale for common acute illnesses (infectious colitis, diverticulitis, pneumonitis, prostatitis, pyelonephritis , ankle sprain) in two emergency ward.

For "before" study without intervention : usual consultation without PIL .

For "after study" with intervention : the patient is given a PIL related to his disease during the consultation.

Data collection will take place the same day as the consultation by self-administered questionnaire for DPC scale and also between 7 to 10 days after the consultation by phone survey for DPC scale and adherence scale.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patient.
  • Minor aged over 15 years accompanied by a responsible adult.
  • The patient must be reachable by telephone within seven to ten days following the consultation.

Exclusion criteria

  • Illiterate patient.
  • Patient refusing follow-up call.
  • Patient with visual or hearing impairment.
  • Patient non-Francophone.
  • Private patient of liberty by judicial or administrative.
  • Person being a measure of legal protection.

Treatment and study plan

Patient Information Leaflet (PIL)

Procedure

Patient Information Leaflet (PIL) about infectious colitis, diverticulitis, pneumonitis, prostatitis or either pyelonephritis is given to the patient related to his disease during the consultation

Primary outcomes

  1. Doctor Patient Communication score

    Time frame: In seven to ten days after delivery

    All patients will be called seven to ten days after the delivery of a PIL during the visit to answer a questionnaire on their perception of Doctor Patient Communication (DPC) since they visit the GP. Il will permit to calculate a DPC score.

Secondary outcomes

  1. Adherence score

    Time frame: In seven to ten days after the delivery

    All patients will be called seven to ten days after the delivery of a PIL during the visit, to answer a questionnaire on their adherence related to the disease since they visit the GP. Il will permit to calculate a adherence score.

  2. Satisfaction score

    Time frame: In seven to ten days after the delivery

    All patients will be called seven to ten days after the visit, to answer a questionnaire on their satisfaction about since they visit the GP. Il will permit to calculate a satisfaction score.

  3. Doctor Patient Communication score

    Time frame: Just after the visit

    All patients will answer to a self questionnaire on their perception of Doctor Patient Communication (DPC) just after the visit of the GP. Il will permit to calculate a DPC score.

Sponsors and collaborators

Lead sponsor

Floralis

Industry

Collaborators

  • Groupe Hospitalier Mutualiste de Grenoble

Registry information

Official study title

Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication and Adherence in Emergency Ward

Acronym: EDIFIP

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Sep 22, 2014
Registry last updated
Aug 27, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.